Why the study?
Does endothelin-A blockade with BQ123 reduce Angiotensin II-induced renal and systemic vasoconstriction in healthy volunteers?
Population
7 healthy volunteers on a 250-mmol sodium diet
Comparison
Angiotensin II infusion combined with… vs Angiotensin II infusion alone
Design
Other
Authors
Loading...
Endothelin-A blockade attenuates Ang II vasoconstriction in healthy volunteers; leaves open therapeutic relevance in hypertension.
Does endothelin-A blockade with BQ123 reduce Angiotensin II-induced renal and systemic vasoconstriction in healthy volunteers?
Endothelin-A receptors contribute substantially to the systemic and renal vasoconstriction induced by low-dose exogenous Angiotensin II in healthy humans.
Montanari et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: